Accelerating cancer immune cell therapies
As we’ve gained a greater understanding of cancer biology, therapeutic interventions have evolved from a one-size-fits-all approach to more targeted approaches, which afford patients not only longer lives but increased quality of life. Cell therapies, including chimeric antigen receptor (CAR) T-cell therapy, are emerging as promising treatments, especially for hematological malignancies.
Explore how 10X Genomics single-cell solutions can help uncover molecular insights into cell therapeutic efficacy and toxicity, transforming the way we approach immune cell therapies for cancer
Many challenges remain in the development of this emerging class of therapeutics, from deepening responses in blood-based tumors to expanding efficacy in solid tumors.
To face these challenges, understanding the mechanisms behind response, resistance, and toxicity to cell therapies is key. Tools with the resolution and scalability to reveal intro and inter-patient heterogeneity across cancer types will enable researchers to identify key biomarkers and optimize therapeutic products.
This Brochure highlights:
- The cutting-edge single cell and spatial analysis solutions offered by 10x Genomics
- The challenges associated with the identification of targets that enhance or deepen the efficacy of cell therapy
And much more!
This content was provided by 10x Genomics
